SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration
16 references·4 citing·29 second hop
Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration (2008)Physiological and Subjective Responses to…Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and Pharmacokinetics (2007)Pharmacological Interaction b…The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans (2006)The effects of fluoxetine on …MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress (2006)MDMA in humans: factors which…Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans (2002)Subjective and hormonal effec…3,4-Methylenedioxymethamphetamine (Ecstasy) and Alcohol Interactions in Humans: Psychomotor Performance, Subjective Effects, and Pharmacokinetics (2002)3,4-Methylenedioxymethampheta…The subjective effects of MDMA and mCPP in moderate MDMA users (2001)The subjective effects of MDM…Gender differences in the subjective effects of MDMA (2001)Gender differences in the sub…The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers (2000)The serotonin uptake inhibito…Pharmacology of MDMA in Humans (2000)Pharmacology of MDMA in HumansHuman Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects (2000)Human Pharmacology of 3,4-Met…Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine: A Double-Blind, Placebo-Controlled Trial (2000)Cardiovascular Effects of 3,4…Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans (1999)Cardiovascular and Neuroendoc…Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)Psychological and Cardiovascu…The Psychological and Physiological Effects of MDMA on Normal Volunteers (1986)The Psychological and Physiol…Subjective Reports of the Effects of MDMA in a Clinical Setting (1986)Subjective Reports of the Eff…MDMA: Nonmedical Use and Intoxication (1986)MDMA: Nonmedical Use and Into…Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review (2013)Pharmacological enhancement o…Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex (2012)Effects of MDMA alone and aft…MDMA: Interactions with other psychoactive drugs (2011)MDMA: Interactions with other…Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers (2011)Effects of the α2-Adrenergic …Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings (1998)Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans (2000)3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings (2006)Profile of mood states (1992)Effects of MDMA on sociability and neural response to social threat and social reward (2009)3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial (2018)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behavioral Measures of Impulsivity: Alone and in Combination with Alcohol (2005)A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers (2006)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (2001)MDMA enhances emotional empathy and prosocial behavior (2013)RETRACTED ARTICLE: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials (2019)Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis (1997)A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) (2012)Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP (2003)A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans (2011)Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study (2012)Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate Campus (1987)Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (2003)A review of the acute subjective effects of MDMA/ecstasy (2006)The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) (2003)Safety pharmacology of acute MDMA administration in healthy subjects (2017)MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder (2008)
this work references cited by second hop

References

  • 1998Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers448 cited
  • 1986Subjective Reports of the Effects of MDMA in a Clinical Setting413 cited
  • 1999Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans362 cited
  • 2001Gender differences in the subjective effects of MDMA359 cited
  • 2000Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects234 cited
  • 2002Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans229 cited
  • 1986The Psychological and Physiological Effects of MDMA on Normal Volunteers226 cited
  • 20023,4-Methylenedioxymethamphetamine (Ecstasy) and Alcohol Interactions in Humans: Psychomotor Performance, Subjective Effects, and Pharmacokinetics191 cited
  • 2001The subjective effects of MDMA and mCPP in moderate MDMA users179 cited
  • 2000Pharmacology of MDMA in Humans179 cited
  • 2000The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers144 cited
  • 2006MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress139 cited
  • 2000Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine: A Double-Blind, Placebo-Controlled Trial

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

138 cited
  • 1986MDMA: Nonmedical Use and Intoxication121 cited
  • 2007Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and Pharmacokinetics113 cited
  • 2006The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans113 cited
  • Cited by

    • 2011MDMA: Interactions with other psychoactive drugs76 cited
    • 2011Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers69 cited
    • 2013Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review67 cited
    • 2012Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex58 cited